GABAX
Price
$51.55
Change
-$0.22 (-0.42%)
Updated
Jul 13 closing price
Net Assets
1.65B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

GABAX vs VFFSX

GABAX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
GABAX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GABAX is a Hold and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. GABAX (1.65B). VFFSX pays higher dividends than GABAX: VFFSX (1.08) vs GABAX (0.35). GABAX was incepted earlier than VFFSX: GABAX (40 years) vs VFFSX (10 years). GABAX (1.35) is less costly to investors than VFFSX (0.01). GABAX is a more actively managed with annual turnover of: 5.00 vs. VFFSX (2.00). GABAX has a lower initial minimum investment than VFFSX: GABAX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. GABAX (5.55). VFFSX return over 5 years is better than : 73.48 vs. GABAX (-15.20).
GABAXVFFSXGABAX / VFFSX
Total Expense Ratio1.350.0113,500%
Annual Report Gross Expense Ratio1.350.0113,500%
Fund Existence40 years10 years-
Gain YTD9.35810.68588%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B1.67T0%
Annual Yield % from dividends0.351.0832%
Returns for 1 year5.5521.0726%
Returns for 3 years1.4968.452%
Returns for 5 years-15.2073.48-21%
Returns for 10 years-9.40251.21-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6